As an FDA official said that the agency has evidence that links COVID vaccines to the deaths of at least 10 children, the U.S ...
U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...
The preventive therapies would be the latest called into question under U.S. Health Secretary Robert F. Kennedy Jr., a long-time promoter of anti-vaccine views.
Federal health officials are reviewing the safety of two injectable drugs used to protect babies and toddlers from the RSV ...
U.S. regulators are reexamining infant RSV antibody treatments as safety questions surface, prompting new FDA scrutiny of ...
Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...
Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...
The US Food and Drug Administration is taking a closer look at RSV shots for infants as Health and Human Services Secretary Robert F. Kennedy Jr. continues to push for changes to the country’s ...
U.S. regulators launch new review of infant RSV therapies from Merck, Sanofi, and AstraZeneca amid scrutiny by Health Secretary Robert F. Kennedy Jr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback